The Myriad of Hematological Challenges of COVID-19 Infection, Peter A. Kouides M.D. Medical and Research Director, Mary M. Gooley Hemophilia Center; Clinical Professor of Medicine, University of Rochester School of Medicine; Attending Hematologist, Rochester General Hospital.
Outline: Consequences of thrombo-inflammatory phenotype of COVID-19 infection... Scope of prevalence of thrombotic manifestations Thromboprophylaxis for whom... Thromboprophylaxis at what dose... Vaccine-induced thrombocytopenia and thrombosis (VITT) Red cell and white cell issues Platelets..
